CAXTON CORP

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1388551 Princeton, NJ

Position in XFOR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$64,250

+$2,022 QoQ

Shares Held

15,557

0.0% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

1.60%

of 13F equity value

Holder Rank

#51

of 82 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAXTON CORP holds $396,089 across 5 Biotechnology names. XFOR ranks #3 (16.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc.	18,773	$162,010
2	LXEO	Lexeo Therapeutics, Inc.	13,943	$80,032
3	XFOR	X4 Pharmaceuticals, Inc This page	15,557	$64,250
4	IKT	Inhibikase Therapeutics, Inc.	28,453	$47,801
5	ALXO	Alx Oncology Holdings Inc	20,946	$41,996

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$64,250	15,557	0.0%	Shares	Sole	2026-05-14
2025-12-31	$62,228	15,557	—	Shares	Sole	2026-02-13
No filing history on record for this holder in this stock.